ArticleMolecular pharmaceutics2015

Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.

Suzanne M D'Addio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.